GDUFA Research Outcomes
Topical Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the topical route, including topical dermatological products.
-
Development and Status of Product-Specific Guidances for Topical Products
Kelchen, Megan
-
Current Trends in Product-Specific Guidance Development & Revisions for Topical Products
Kelchen, Megan
-
An Overview of the Current Product-Specific Guidances for Topical Products
Kelchen, Megan
-
General Considerations for the ���No Significant Difference� Evaluation of a Proposed Generic Formulation
Kelchen, Megan
-
���No Difference� Standard vs. Q1/Q2 Sameness for Topical Drug Products
Kelchen, Megan
-
An FDA Perspective on the Comparative Analyses of Critical Material, Quality, and Design Attributes for Topical, Transdermal, Rectal, and Vaginal Drug-Device Combination Products
Kelchen, Megan
-
The Development And Application Of Surrogate Methods To Assess Bioequivalence Of Topical Generic Products Intended For Local Action
Kanfer,Isadore
-
Bioequivalence Evaluation of Narrow Therapeutic Index Drugs – Rationales for the Current Regulatory Approach by U.S. FDA
Jiang, Wenlei
-
U.S. FDA Recommendation on Bioequivalence Demonstration of Topical Drug Products
Jiang, Wenlei
-
Generic Versions of Narrow Therapeutic Index Drugs National Survey of Pharmacists’ Substitution Beliefs and Practices
Jiang, Wenlei